Does Myeloid or Lymphoid Origin of Hematologic Neoplasm Affect Pulmonary Functions, Muscle Strength, Exercise Capacity, Fatigue and Quality of Life? View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2012-2017

ABSTRACT

Hematologic malignancies may arise from myeloid and lymphoid blood cells lineages affecting blood, bone marrow and lymph nodes. Accordingly, negative effects of malignancies on body systems vary. As known, muscle strength, exercise capacity, fatigue and quality of life deteriorate during allogeneic hematopoietic stem cell transplantation (HSCT). However, impacts of myeloid and lymphoid type disorders on pulmonary functions, muscle strength, exercise capacity, fatigue and quality of life in allogeneic-HSCT who diagnosed with hematologic malignancies. Therefore, current study aimed to comparatively investigate physical impairments between recipients with hematologic malignancies according to myeloid and lymphoid type disorder. Detailed Description Hematologic malignancies affecting blood, bone marrow and lymph nodes comprise neoplasm of either myeloid or lymphoid blood stem cells origin. While a lymphoid stem cell becomes a white blood cell, a myeloid stem cell becomes one of the red blood cells, white blood cells or platelets types. Due to the this reason, defects in myeloid stem cells result in acute and chronic myelogenous leukemia, myelodysplastic syndromes or myeloproliferative diseases, whereas defects in lymphoid stem cells result in lymphomas, lymphocytic leukemias or myeloma. On the other hand, most of these hematologic malignancies are characterized with high rate of morbidity and mortality because of both the nature and various toxic treatments of neoplasm including chemotherapy with multiple agents, corticosteroids and hematopoietic stem cell transplantation (HSCT). Especially after allogeneic-HSCT, recipients experience more impairments in pulmonary functions, respiratory and peripheral muscle strength, exercise capacity, perception of fatigue and quality of life scores which make their lives difficult in terms of actively trying to return to the their life. However, although it has been known that each hematologic disease has a different negative impact on varied body systems or organs after HSCT, little attention has been paid to the comparatively investigation of impacts of myeloid and lymphoid hematological malignancies on pulmonary functions, muscle strength, exercise capacity, fatigue and quality of life in allogeneic-HSCT recipients. Hence, current study aimed to comparatively investigate physical impairments between recipients with hematologic malignancies according to myeloid and lymphoid type disorder. Recipients undergone allogeneic-HSCT (˃100 days post-HSCT status) were included. Hematologic malignancies were grouped as myeloid and lymphoid. Pulmonary functions (spirometry), peripheral (dynamometer) and respiratory muscle strength (MIP-MEP) (mouth pressure device), exercise capacity (Modified Incremental Shuttle Walk Test (ISWT)), fatigue (Fatigue Severity Scale) and quality of life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) were evaluated. More... »

URL

https://clinicaltrials.gov/show/NCT03699358

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3048", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Hematologic malignancies may arise from myeloid and lymphoid blood cells lineages affecting blood, bone marrow and lymph nodes. Accordingly, negative effects of malignancies on body systems vary. As known, muscle strength, exercise capacity, fatigue and quality of life deteriorate during allogeneic hematopoietic stem cell transplantation (HSCT). However, impacts of myeloid and lymphoid type disorders on pulmonary functions, muscle strength, exercise capacity, fatigue and quality of life in allogeneic-HSCT who diagnosed with hematologic malignancies. Therefore, current study aimed to comparatively investigate physical impairments between recipients with hematologic malignancies according to myeloid and lymphoid type disorder.\n\nDetailed Description\nHematologic malignancies affecting blood, bone marrow and lymph nodes comprise neoplasm of either myeloid or lymphoid blood stem cells origin. While a lymphoid stem cell becomes a white blood cell, a myeloid stem cell becomes one of the red blood cells, white blood cells or platelets types. Due to the this reason, defects in myeloid stem cells result in acute and chronic myelogenous leukemia, myelodysplastic syndromes or myeloproliferative diseases, whereas defects in lymphoid stem cells result in lymphomas, lymphocytic leukemias or myeloma. On the other hand, most of these hematologic malignancies are characterized with high rate of morbidity and mortality because of both the nature and various toxic treatments of neoplasm including chemotherapy with multiple agents, corticosteroids and hematopoietic stem cell transplantation (HSCT). Especially after allogeneic-HSCT, recipients experience more impairments in pulmonary functions, respiratory and peripheral muscle strength, exercise capacity, perception of fatigue and quality of life scores which make their lives difficult in terms of actively trying to return to the their life. However, although it has been known that each hematologic disease has a different negative impact on varied body systems or organs after HSCT, little attention has been paid to the comparatively investigation of impacts of myeloid and lymphoid hematological malignancies on pulmonary functions, muscle strength, exercise capacity, fatigue and quality of life in allogeneic-HSCT recipients. Hence, current study aimed to comparatively investigate physical impairments between recipients with hematologic malignancies according to myeloid and lymphoid type disorder. Recipients undergone allogeneic-HSCT (\u02c3100 days post-HSCT status) were included. Hematologic malignancies were grouped as myeloid and lymphoid. Pulmonary functions (spirometry), peripheral (dynamometer) and respiratory muscle strength (MIP-MEP) (mouth pressure device), exercise capacity (Modified Incremental Shuttle Walk Test (ISWT)), fatigue (Fatigue Severity Scale) and quality of life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) were evaluated.", 
    "endDate": "2017-12-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03699358", 
    "keywords": [
      "origin", 
      "Hematologic Neoplasm", 
      "pulmonary function", 
      "muscle strength", 
      "exercise capacity", 
      "fatigue", 
      "life", 
      "blood cell lineage", 
      "blood", 
      "bone marrow", 
      "lymph node", 
      "negative effect", 
      "malignancy", 
      "body system", 
      "deteriorate", 
      "hematopoietic stem cell transplantation", 
      "disorder", 
      "current study", 
      "physical impairment", 
      "recipient", 
      "Neoplasm", 
      "blood stem cell", 
      "Lymphoid Progenitor Cell", 
      "leukocyte", 
      "Myeloid Progenitor Cell", 
      "Erythrocyte", 
      "defect", 
      "cell result", 
      "leukemia", 
      "myelodysplastic syndrome", 
      "myeloproliferative disease", 
      "lymphoma", 
      "Lymphoid Leukemia", 
      "myeloma", 
      "high rate", 
      "morbidity", 
      "mortality", 
      "nature", 
      "toxic treatment", 
      "Drug Therapy", 
      "multiple agent", 
      "corticosteroid", 
      "impairment", 
      "perception", 
      "life score", 
      "Hematologic Disease", 
      "negative impact", 
      "organ", 
      "status", 
      "spirometry", 
      "dynamometer", 
      "respiratory muscle", 
      "MIP", 
      "pressure", 
      "shuttle", 
      "severity", 
      "quality of life"
    ], 
    "name": "Does Myeloid or Lymphoid Origin of Hematologic Neoplasm Affect Pulmonary Functions, Muscle Strength, Exercise Capacity, Fatigue and Quality of Life?", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03699358"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00028.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.25769.3f", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.10359.3e", 
        "type": "Organization"
      }
    ], 
    "startDate": "2012-03-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/s00520-015-2744-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009622931", 
          "https://doi.org/10.1007/s00520-015-2744-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/phm.0b013e31820be055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011264073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd009075.pub2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028703276"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03699358"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03699358'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03699358'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03699358'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03699358'


 

This table displays all metadata directly associated to this object as RDF triples.

88 TRIPLES      16 PREDICATES      76 URIs      66 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03699358 schema:about anzsrc-for:3048
2 schema:description Hematologic malignancies may arise from myeloid and lymphoid blood cells lineages affecting blood, bone marrow and lymph nodes. Accordingly, negative effects of malignancies on body systems vary. As known, muscle strength, exercise capacity, fatigue and quality of life deteriorate during allogeneic hematopoietic stem cell transplantation (HSCT). However, impacts of myeloid and lymphoid type disorders on pulmonary functions, muscle strength, exercise capacity, fatigue and quality of life in allogeneic-HSCT who diagnosed with hematologic malignancies. Therefore, current study aimed to comparatively investigate physical impairments between recipients with hematologic malignancies according to myeloid and lymphoid type disorder. Detailed Description Hematologic malignancies affecting blood, bone marrow and lymph nodes comprise neoplasm of either myeloid or lymphoid blood stem cells origin. While a lymphoid stem cell becomes a white blood cell, a myeloid stem cell becomes one of the red blood cells, white blood cells or platelets types. Due to the this reason, defects in myeloid stem cells result in acute and chronic myelogenous leukemia, myelodysplastic syndromes or myeloproliferative diseases, whereas defects in lymphoid stem cells result in lymphomas, lymphocytic leukemias or myeloma. On the other hand, most of these hematologic malignancies are characterized with high rate of morbidity and mortality because of both the nature and various toxic treatments of neoplasm including chemotherapy with multiple agents, corticosteroids and hematopoietic stem cell transplantation (HSCT). Especially after allogeneic-HSCT, recipients experience more impairments in pulmonary functions, respiratory and peripheral muscle strength, exercise capacity, perception of fatigue and quality of life scores which make their lives difficult in terms of actively trying to return to the their life. However, although it has been known that each hematologic disease has a different negative impact on varied body systems or organs after HSCT, little attention has been paid to the comparatively investigation of impacts of myeloid and lymphoid hematological malignancies on pulmonary functions, muscle strength, exercise capacity, fatigue and quality of life in allogeneic-HSCT recipients. Hence, current study aimed to comparatively investigate physical impairments between recipients with hematologic malignancies according to myeloid and lymphoid type disorder. Recipients undergone allogeneic-HSCT (˃100 days post-HSCT status) were included. Hematologic malignancies were grouped as myeloid and lymphoid. Pulmonary functions (spirometry), peripheral (dynamometer) and respiratory muscle strength (MIP-MEP) (mouth pressure device), exercise capacity (Modified Incremental Shuttle Walk Test (ISWT)), fatigue (Fatigue Severity Scale) and quality of life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) were evaluated.
3 schema:endDate 2017-12-01T00:00:00Z
4 schema:keywords Drug Therapy
5 Erythrocyte
6 Hematologic Disease
7 Hematologic Neoplasm
8 Lymphoid Leukemia
9 Lymphoid Progenitor Cell
10 MIP
11 Myeloid Progenitor Cell
12 Neoplasm
13 blood
14 blood cell lineage
15 blood stem cell
16 body system
17 bone marrow
18 cell result
19 corticosteroid
20 current study
21 defect
22 deteriorate
23 disorder
24 dynamometer
25 exercise capacity
26 fatigue
27 hematopoietic stem cell transplantation
28 high rate
29 impairment
30 leukemia
31 leukocyte
32 life
33 life score
34 lymph node
35 lymphoma
36 malignancy
37 morbidity
38 mortality
39 multiple agent
40 muscle strength
41 myelodysplastic syndrome
42 myeloma
43 myeloproliferative disease
44 nature
45 negative effect
46 negative impact
47 organ
48 origin
49 perception
50 physical impairment
51 pressure
52 pulmonary function
53 quality of life
54 recipient
55 respiratory muscle
56 severity
57 shuttle
58 spirometry
59 status
60 toxic treatment
61 schema:name Does Myeloid or Lymphoid Origin of Hematologic Neoplasm Affect Pulmonary Functions, Muscle Strength, Exercise Capacity, Fatigue and Quality of Life?
62 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03699358
63 schema:sdDatePublished 2019-03-07T15:28
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher Nd2fb165bd64b41f88d4acd44b3962260
66 schema:sponsor https://www.grid.ac/institutes/grid.10359.3e
67 https://www.grid.ac/institutes/grid.25769.3f
68 schema:startDate 2012-03-01T00:00:00Z
69 schema:subjectOf sg:pub.10.1007/s00520-015-2744-3
70 https://doi.org/10.1002/14651858.cd009075.pub2
71 https://doi.org/10.1097/phm.0b013e31820be055
72 schema:url https://clinicaltrials.gov/show/NCT03699358
73 sgo:license sg:explorer/license/
74 sgo:sdDataset clinical_trials
75 rdf:type schema:MedicalStudy
76 Nd2fb165bd64b41f88d4acd44b3962260 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 anzsrc-for:3048 schema:inDefinedTermSet anzsrc-for:
79 rdf:type schema:DefinedTerm
80 sg:pub.10.1007/s00520-015-2744-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009622931
81 https://doi.org/10.1007/s00520-015-2744-3
82 rdf:type schema:CreativeWork
83 https://doi.org/10.1002/14651858.cd009075.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028703276
84 rdf:type schema:CreativeWork
85 https://doi.org/10.1097/phm.0b013e31820be055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011264073
86 rdf:type schema:CreativeWork
87 https://www.grid.ac/institutes/grid.10359.3e schema:Organization
88 https://www.grid.ac/institutes/grid.25769.3f schema:Organization
 




Preview window. Press ESC to close (or click here)


...